Presentations from Symposia at ESPEN 2015 in Lisbon, Portugal and EUGMS 2015 in Oslo, Norway

Breakthrough Scientific Data and Clinical Evidence Supporting the Use of HMB to Optimize Health and Disease Management - Introduction

Refaat Hegazi, MD, PhD, MS, MPH, ABPNS
Medical Director, Abbott Nutrition
Columbus, Ohio, USA

Lean body mass (LBM) / muscle is important for healthy aging and disease management. Both aging and immobility independently cause decreased protein synthesis. Inflammatory cytokines released during illness or injury further stimulate protein breakdown and accelerate LBM loss.

These drivers of LBM loss in aging, accompanied by decreased dietary intake and infiltration of fat into muscle result in frailty, sarcopenia with reduced strength and function, and a rapid loss in quality of life.

World-renowned researchers in LBM and sarcopenia present new scientific and clinical data on the benefits of β-hydroxy-β-methylbutyrate (HMB) and oral nutritional supplements (ONS) high in protein and vitamin D in rebuilding muscle mass, helping to prevent sarcopenia, or for improved management of sarcopenia.

*at no charge